Alex Chenchik
Dr. Alex Chenchik, president and chief scientific officer of Cellecta, Inc. founded the company in 2006. Cellecta is focused on the development and application of next-generation functional genomic and other technologies for biomarker and drug target discovery and validation. Dr. Chenchik received his doctorate in Molecular Biology from the Institute of Molecular Biology, Moscow, Russia. He has authored over 50 publications and holds 15 issued patents.
Abstracts this author is presenting:
